|
1.International Agency for Research on Cancer. Tobacco Habits Other Than Smoking; Betel-quid and Areca-nut Chewing; and Some Related Nitrosamines. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans 1985; 37. Available at: http://monographs.iarc.fr/ENG/Monographs/vol1-42/mono37.pdf. Accessed october 23-30, 1984. 2.International Agency for Research on Cancer. Betel quid and areca-nut chewing and some areca-nut derived nitrosamines. Paper presented at the IARC Monogr Eval Carcinog Risks Hum 2004; 85. Available at: http://monographs.iarc.fr/ENG/Monographs/vol85/mono85.pdf. Accessed october 11-18, 1984. 3.International Agency for Research on Cancer. A review of human carcinogens: personal habits and indoor combustions. Paper presented at the IARC Monogr Eval Carcinog Risks Hum 2012; 100E. Available at: http://monographs.iarc.fr/ENG/Monographs/vol100E/mono100E.pdf. Accessed September 29-October 6, 2009. 4.Ko YC, Huang YL, Lee CH, Chen MJ, Lin LM, Tsai CC. Betel quid chewing, cigarette smoking and alcohol consumption related to oral cancer in Taiwan. J Oral Pathol Med. 1995; 24: 450–453. 5.Tsai JF, Jeng JE, Chuang LY, Ho MS, Ko YC, Lin ZY, Hsieh MY, Chen SC, Chuang WL, Wang LY, Yu ML, Dai CY.Habitual betel quid chewing and risk for hepatocellular carcinoma complicating cirrhosis. Medicine (Baltimore). 2004; 83:176–187. 6.Lee KW, Kuo WR, Tsai SM, Wu DC, Wang WM, Fang FM, Chiang FY, Ho KY, Wang LF, Tai CF, Kao EL, Chou SH, Lee CH, Chai CY, Ko YC. Different impact from betel quid, alcohol and cigarette: risk factors for pharyngeal and laryngeal cancer. Int J Cancer. 2005; 117: 831–836. 7.Wu IC, Lu CY, Kuo FC, Tsai SM, Lee KW, Kuo WR, Cheng YJ, Kao EL, Yang MS, Ko YC. Interaction between cigarette, alcohol and betel nut use on esophageal cancer risk in Taiwan. Eur J Clin Invest. 2006; 36: 236–241. 8.Lin CF, Wang JD, Chen PH, Chang SJ, Yang YH, Ko YC. Predictors of betel quid chewing behavior and cessation patterns in Taiwan aborigines. BMC Public Health. 2006; 6: 271. 9.Lan TY, Chang WC, Tsai YJ, Chuang YL, Lin HS, Tai TY. Areca nut chewing and mortality in an elderly cohort study. Am J Epidemiol. 2007; 165: 677–683. 10.Guh JY, Chuang LY, Chen HC. Betel-quid use is associated with the risk of the metabolic syndrome in adults. Am J Clin Nutr. 2006; 83: 1313–1320. 11.Yang MS, Lee CH, Chang SJ, Chung TC, Tsai EM, Ko AM, Ko YC. The effect of maternal betel quid exposure during pregnancy on adverse birth outcomes among aborigines in Taiwan. Drug Alcohol Depend. 2008; 95: 134-139. 12.Lee CH, Ko AM, Warnakulasuriya S, et al. Intercountry prevalences and practices of betel-quid use in south, southeast and eastern Asia regions and associated oral preneoplastic disorders: an international collaborative study by Asian betel-quid consortium of south and east Asia. Int J Cancer. 2011; 129: 1741–1751. 13.Nelson BS, Heischober B. Betel nut: a common drug used by naturalized citizens from India, Far East Asia, and the South Pacific Islands. Ann Emerg Med. 1999; 34: 238–243. 14.Sharan RN, Mehrotra R, Choudhury Y, et al. Association of betel nut with carcinogenesis: revisit with a clinical perspective. PLoS One. 2012; 7: e42759. 15.Pickwell SM, Schimelpfening S, Palinkas LA. ‘Betel mania’. Betel quid chewing by Cambodian women in the United States and its potential health effects. West J Med. 1994; 160: 326–330. 16.Boucher BJ, MannanN. Metabolic effects of the consumption of Areca catechu. Addict Biol. 2002; 7: 103–110. 17.Ko YC, Chiang TA, Chang SJ, Hsieh SF. Prevalence of betel quid chewing habit in Taiwan and related sociodemographic factors. J Oral Pathol Med. 1992; 21: 261–264. 18.Lee CH, Chiang SL, Ko AM, et al. Betel-quid dependence domains and syndrome associated with betel-quid ingredients among chewers: an Asian multi-country evidence. Addiction. 2014; 109: 1194-1204. 19.Strickland SS. Anthropological perspectives on use of the areca nut. Addict Biol. 2002; 7: 85-97. 20.Lee CH, Ko AM, Yen CF, Chu KS, Gao YJ, Warnakulasuriya S, Sunarjo, Ibrahim SO, Zain RB, Patrick WK, Ko YC. Betel-quid dependence and oral potentially malignant disorders in six Asian countries. Br J Psychiatry. 2012; 201: 383-391. 21.Lee CH, Ko AM, Yang FM, Hung CC, Warnakulasuriya S, Ibrahim SO, Zain RB, Ko YC. Association of DSM-5 Betel-Quid Use Disorder With Oral Potentially Malignant Disorder in 6 Betel-Quid Endemic Asian Populations. JAMA Psychiatry. 2018; 75: 261-269. 22.Yang MS, Su IH, Wen JK, Ko YC. Prevalence and related risk factors of betel quid chewing by adolescent students in southern Taiwan. J Oral Pathol Med. 1996; 25:69–71 23.van Amsterdam J, Talhout R, Vleeming W, et al. Contribution of monoamine oxidase (MAO) inhibition to tobacco and alcohol addiction. Life Sci. 2006; 79: 1969-1973. 24.Chen PH, Tu HP, Wang SJ, et al. Monoamine oxidase A variants are associated with heavy betel quid use. Addict Biol. 2012; 17: 786-797. 25.Chung CM, Kuo TM, Chiang SL, Wang ZH, Hung CC, Lane HY, et al. Antidepressants in association with reducing risk of oral cancer occurrence: a nationwide population-based cohort and nested case-control studies. Oncotarget. 2016; 7: 11687-11695. 26.Le, MS, Shueng, PW, Yu, LH & Koustuv, D. Evaluation of Effectiveness of the 3A3R Educational Intervention Program for Betel Nut Addicts. Health Medicine 2014; 8: 1303-1310. 27.Osborne, PG, Ko, YC, Wu, MT & Lee, CH. Intoxication and substance use disorder to Areca catechu nut containing betel quid: A review of epidemiological evidence, pharmacological basis and social factors influencing quitting strategies. Drug and Alcohol Dependence. 2017; 179: 187-197. 28.Shankman SA, Funkhouser CJ, Klein DN, Davila J, Lerner D, Hee D. Reliability and validity of severity dimensions of psychopathology assessed using the Structured Clinical Interview for DSM‐5 (SCID), Int J Methods Psychiatr Res. 2018; 27: e1590. 29.O’Brien CP. Anticraving medications for relapse prevention: a possible new class of psychoactive medications. Am J Psychiatry. 2005; 162: 1423–1431. 30.Tiffany ST, Wray JM. The clinical significance of drug craving. Ann NY Acad Sci. 2012; 1248: 1–17 31.Deborah S Hasin, Charles P O''Brien, Marc Auriacombe, Guilherme Borges, Kathleen Bucholz, Alan Budney, Wilson M Compton, Thomas Crowley, Walter Ling, Nancy M Petry, Marc Schuckit, Bridget F Grant. DSM-5 criteria for substance use disorders: recommendations and rationale. Am J Psychiatry. 2013; 170 (8): 834-851. 32.Connor JP, Feeney GF and Young RM. A comparison of the Yale-Brown Obsessive Compulsive Scale for ‘heavy drinking’ with a single item craving measure: construct validity and clinical utility. Substance Use & Misuse. 2005; 40: 551–561. 33.Gau SS, Liu CY, Lee CS, Chang JC, Chang CJ, Li CF, Chen CC and Cheng AT. Development of a Chinese version of the Yale-Brown obsessive compulsive scale for heavy drinking. Alcoholism: Clinical and Experimental Research. 2005; 29: 1172–1179. 34.Hamilton M. A rating scale for depression. Journal of Neurology, Neurosurgery, and Psychiatry. 1960; 23: 56–62. 35.Beck AT, Epstein N, Brown G and Steer RA. An inventory for measuring clinical anxiety: psychometric properties. Journal of Consulting and Clinical Psychology. 1988; 56: 893–897. 36.Beck AT, Steer RA, Ball R and Ranieri W. Comparison of Beck Depression Inventories-IA and -II in psychiatric outpatients. Journal of Personality Assessment. 1996; 67: 588–597 37.Hu, CW, Chang, YZ, Wang, HW & Chao, MR. High-throughput simultaneous analysis of five urinary metabolites of areca nut and tobacco alkaloids by isotope-dilution liquid chromatography-tandem mass spectrometry with on-line solid-phase extraction. Cancer Epidemiology, Biomarkers & Prevention. 2010; 19: 2570-2581. 38.Carew, TJ & Sutton, MA. Molecular stepping stones in memory consolidation. Nature Neuroscience. 2001; 4: 769-771. 39.Holahan, MR & Routtenberg, A. Post-translational synaptic protein modification as substrate for long-lasting, remote memory: an initial test. Hippocampus. 2007; 17: 93-97. 40.Routtenberg, A & Rekart, JL. Post-translational protein modification as the substrate for long-lasting memory. Trends in Neurosciences. 2005; 28: 12-19. 41.Lin, CC, Tami-Maury, I, Ma, WF, Lam, C, Tsai, MH, Lin, MT, Li, CI, Liu, CS, Li, TC, Chiu, CF, Lu, IY & Gritz, ER. Social and Cultural Context of Betel Quid Consumption in Taiwan and Implications for Prevention and Cessation Interventions. Substance Use & Misuse. 2017; 52: 646-655. 42.Moss, J, Kawamoto, C, Pokhrel, P, Paulino, Y & Herzog, T. Developing a Betel Quid Cessation Program on the Island of Guam. Pacific Asia Inquiry. 2015; 6: 144-150.
|